Mitomycin, Ifosfamide, and Cisplatin in Unresectable Non–Small-Cell Lung Cancer: Effects on Survival and Quality of Life
M.H. Cullen(University Hospitals Birmingham NHS Foundation Trust), R L Souhami(University Hospitals Birmingham NHS Foundation Trust), Stephen Spiro(The University of Texas at Dallas), Colin Trask(University Hospitals Birmingham NHS Foundation Trust), A.D. Chetiyawardana(University Hospitals Birmingham NHS Foundation Trust), J. E. Cook(Kansas State University), D. Ferry(University Hospitals Birmingham NHS Foundation Trust), C.K. Connolly(University Hospitals Birmingham NHS Foundation Trust), Jeffrey Tobias(University Hospitals Birmingham NHS Foundation Trust), RameshC. Joshi(University Hospitals Birmingham NHS Foundation Trust), C.M. Woodroffe(University Hospitals Birmingham NHS Foundation Trust), N.H. Gower(University Hospitals Birmingham NHS Foundation Trust), Lucinda Billingham(University Hospitals Birmingham NHS Foundation Trust), R.M. Rudd(University of Nottingham), E.M. Bessell(University Hospitals Birmingham NHS Foundation Trust)
Cited by 449
Related Papers
Atrial High Rate Episodes Detected by Pacemaker Diagnostics Predict Death and Stroke
|Circulation|2003|753
One Hundred Years of Lung Cancer
|American Journal of Respiratory and Critical Care Medicine|2005|384
On defining resurgence
|Behavioural Processes|2017|139
Guide for Selecting Proportions for High-Strength Concrete Using Portland Cement and Other Cementitious Materials
|Unknown|2008|87
Global Measures of Treatment Integrity May Mask Important Errors in Discrete-Trial Training
|Behavior Analysis in Practice|2015|61